Histopathological and ultrastructural aspects of mice lungs experimentally infected with dengue virus serotype 2

Memorias do Instituto Oswaldo Cruz

Volumn 102, Issue 2, 2007, Pages 175-182

  Barreto, Débora Ferreira ^a   Takiya, Christina Maeda ^b   Schatzmayr, Hermann Gonçalves ^a   Nogueira, Rita Maria Ribeiro ^a   Farias Filho, José Da Costa ^a   Barth, Ortrud Monika ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

BALB c mice; C6 36 cell line; Dengue 2 virus; Macrophage; Mast cell; Ultrastructure

Indexed keywords

DENGUE VIRUS; DENGUE VIRUS TYPE 2; MUS;

EID: 34047232163     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762007000200009     Document Type: Article

References (41)

1. An J, Kimura-Kuroda J, Hirabayashi Y, Yasui K 1999. Development of novel mouse model for dengue virus infection. Virology 263: 70-77.
2. Atrasheuskaya A, Petzelbauer P, Fredeking TM, Ignatyev G 2003. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol Med Microbiol 35: 33-42.
3. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husman M 1998. Dengue virus infection in human endothelial cells leads to chemokine production, complement activation and apoptosis. J Immunol 161: 6338-6346.
4. Barreto DF, Takiya CM, Paes MV, Farias-Filho J, Pinhão AT, Alves AM, Costa SM, Barth OM 2004. Histopathological aspects of dengue-2 virus infected mice tissues and complementary virus isolation. J Submicrosc Cytol Pathol 36: 121-30.
5. Bhamarapravati N 1989. Homostatic defects in dengue hemorrhagic fever. Rev Infect Dis 11(Suppl. 4): S826-829.
6. Bhamarapravati N 1993. Pathology of dengue haemorrhagic fever. In P Thong-charoen, Monograph on Dengue/Dengue Haemorrhagic Fever, WHO-SEARO, New Delhi 22, p. 72-79.
7. Boonpucknavig S, Vuttiviroj O, Boonpucknavig V 1981. Infection of young adult mice with dengue virus type 2. Trans R Soc Trop Med Hyg 75: 647-653.
8. Burke DS, Nisalak A, Johnson DE, Scott RM 1988. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38: 172-180.
9. Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, Fletterick RJ, Rice CM 1990. Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleaveages in the viral polyprotein. Proc Natl Acad Sci USA 87: 8898-8902.
10. Chaturvedi UC, Dhawan R, Khanna M, Mathur A 1991. Breakdown of the blood-brain barrier during dengue virus infection of mice. J Gen Virol 72: 859-866.
11. Cole GA, Wisseman Jr CL 1969. Pathogenesis of type 1 dengue virus infection in suckling weanling and adult mice. The relation of virus replication interferon and antibody formation. Am J Epidemiol 89: 669-680.
12. Desprès P, Frenkiel M-P, Ceccaldi P-E, Dos Santos CD, Deubel V 1998. Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J Virol 72: 823-829.
13. Feroze NG 1997. Ultrastructural Pathology on the Cell and Matrix, 4th ed., p. 619-1414.
14. Fox B, Bull TB, Guz A 1981. Mast cells in the human alveolar wall: an electronmicroscopic study. J Clin Pathol 34: 1333-1342.
15. Halstead SB 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239(4839): 476-481.
16. Halstead SB, O'Rourke EJ 1977. Dengue viruses and mononuclear phagocytes. Infection enhacement by non-neutralizing antibody. J Exp Med 146: 201-217.
17. Henchal FA, Putnak JR 1990. The dengue viruses. Clin Microbiol Rev 3: 376-396.
18. Hotta H, Murakami I, Miyasaki K, Takeda Y, Shirane H, Hotta S 1981a. Inoculation of dengue virus into nude mice. J Gen Virol 52: 71-76.
19. Hotta H, Murakami I, Miyasaki K, Takeda Y, Shirane H, Hotta S 1981b. Localization of dengue virus in nude mice. Microbiol Immunol 25: 89-93.
20. Huang CY, Butrapet S, Tsuchya KR, Bhamarapravati N, Gubler DJ, Kinney RM 2003. Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccien development. J Virol 77: 11436-47.
21. Huang K-J, Li S-Y L, Chen S-C, Liu H-S, Lin Y-S, Yeh T-M, Liu C-C, Lei H-Y 2000. Manifestation of thrombocytopenia in dengue-2 virus-infected mice. J Gen Virol 81: 2177-2182.
22. Humprey CD, Pittman EE 1974. A simple methylene blue-azure-II basic fuchsin for epoxy-embedded tissue sections. Stain Technol 49: 9.
23. Innis B 1995. Dengue and dengue hemorrhagic fever. In JS Porterfield, Kass Handbook of Infectious Disease; Exotic Viral Infections, Chapman Hall, London, p. 103-146.
24. Johnson AJ, Roehrig JT 1999. New mouse model for degue virus vaccine testing. J Virol 73: 783-786.
25. Juffrie M, Meer DM, Hack CE, Haasnoot K, Sutaryo, Veerman AJ, Thijs LG 2000. Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun 68: 702-707.
26. Khanna M, Chaturvedi UC, Sharma MC, Pandey VC, Mathur A 1990. Increased capillary permeability mediated by dengue virus-induced lymphokine. Immunology 69: 449-453.
27. King CA, Anderson R, Marshalli JS 2002. Dengue virus selectively induces human mast cell chemokine production. J Virol 8408-8419.
28. Lin Y, Liao CL, Chen LK, Yeh CT, Liu CI, Ma SH, Huang YY, Huang YL, Kao CL, King CC 1998. Study of dengue virus infection in SCID mice engrafted with human K562 cells. J Virol 72: 9729-9737.
29. Lucia HL, Kangwanpong D 1994. Identification of dengue virus-infected cells in paraffin-embedded tissue using in situ polymerase chain reaction and DNA hybridization. J Virol Methods 48: 1-8.
30. Marchette NJ, Halstead SB, Falkler WA Jr, Stenhouse A, Nash D 1973. Studies on the pathogenesis of dengue infection in monkeys. 3. Sequencial distribuition of the virus in primary and heterologous infection. J Infect Dis 128: 23-30.
31. Meiklejohn G, England B, Lennette EH 1952. Adaptation of dengue virus strains in unweaned mice. Am J Trop Med Hyg 1: 51-58.
32. Miagostovich MP, Ramos RG, Nicol AF, Nogueira RMR, Cuzzi-Maya T, Oliveira AV, Marchevsky RS, Mesquita RP, Schatzmayr HG 1997. Retrospective study on dengue fatal cases. Clin Neuropathol 16: 204-208.
33. Na J, Zhou DS, Kawasaki K, Yasui K 2003. The pathogenesis of spinal cord involvement in dengue virus infection. Virchows Arch 442: 472-481.
34. Paes MV, Pinhão AT, Barreto DF, Costa SM, Oliveira MP, Nogueira AC, Takiya CM, Farias-Filho JC, Schatzmayr HG, Alves AMB, Barth OM 2005. Liver injury and viremia in mice infected with dengue-2 virus. Virology 338: 236-246.
35. Raut CG, Deolankar RP, Kolhapure RM, Goverdhan MK 1996. Susceptibility of laboratory-bred rodents to the experimental infection with dengue virus type 2. Acta Virol 40: 143-146.
36. Reed LJ, Muench H 1938. A simple method of stimating fifty percent endpoints. Am J Trop Med Hyg 27: 493-497.
37. Reynolds 1963. The use of lead citrate at high pH as an electron opaque stain in electron microscopy. J Cell Biol 17: 208-212.
38. Rothman AL, Ennis FA 1999. Immunopathogenesis of dengue hemorrhagic fever. Virology 257: 1-6.
39. Russel PK 1971. Immunopathological mechanism in the dengue shock syndrome. Prog Immunol 1: 831.
40. Scott RM, Nisalak A, Cheamudon U, Seridhoranakul S, Nimmannitya S 1980. Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis 141: 1-6.
41. Tuchinda M, Dhorreinintra B, Tuchinda P 1977. Histamine content in 24 hours urine in patients with dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 8: 80.